The effect of aurintricarboxylic acid (ATA) was tested on various aspects of protein synthesis directed by the natural messenger ribonucleic acid (RNA) isolated from R17 RNA bacteriophage. The effects of various levels of ATA (up to 1, 000 ,uM) were tested on overall protein synthesis as well as on binding of messenger RNA and fmet-transfer RNA to ribosomes and on the addition of the 50S ribosome to the 30S ribosome initiation complex. All of the reactions tested could be inhibited by ATA, and none of the tested steps was found to be uniquely sensitive to it. However, the total initiation steps were more sensitive to this chemical than the elongation steps; thus, under appropriate conditions this chemical can preferentially inhibit initiation while elongation of the polypeptide chain is not appreciably affected.
The trimethylpentane dye aurintricarboxylate (ATA) has been used as a novel inhibitor of protein synthesis in vitro (4, 6, 10, 12) . It has been proposed that this compound functions by specifically inhibiting the attachment of messenger ribonucleic acid (mRNA) to the ribosome (4).
Our studies on the effect of ATA on polyphenylalanine syntheses directed by polyuridylic acid (Siegelman and Apirion, J. Bacteriol., in press), as well as the studies by Weissbach and Brot (1 1) , suggested that ATA can interfere with other steps in protein synthesis besides binding of messenger.
The available experiments (4, 10, 12) demonstrated inhibition of the initiation complex by ATA when a natural messenger was used, but did not show which of the steps involved in the complex formation is affected. Therefore, we studied the effects of ATA on protein synthesis directed by the natural mRNA, isolated from R 17 bacteriophage, in Escherichia coli cell-free extracts.
Overall protein synthesis as well as specific steps in the initiation process were studied. We found that all steps tested were almost equally sensitive to ATA inhibition. However, we found concentrations of ATA that completely inhibited initiation of protein synthesis without appreciably affecting elongation. Therefore, we suggest that none of the initiation steps is uniquely sensitive to ATA, but it is rather the total sum of the initiation steps that are more sensitive to ATA inhibition than the total elongation steps. Thus, this drug (ATA) is still a unique inhibitor of protein synthesis.
MATERIALS AND METHODS
Radioisotopes. L-'4C-methionine (51 mCi/mmole) was purchased from Schwarz BioResearch Inc., 35S-methionine (910 mCi/mmole) was purchased from Amersham-Searle, 32P-phosphate (5 mCi/ml) was purchased from Schwarz BioResearch Inc., and 3H-R17 RNA was a gift from M. Kuwano of this laboratory.
Chemicals. ATA was purchased from Aldrich Chemical Co., polyadenylic-uridylic-guanylic acid (poly AUG; a 1: 1: I random copolymer) was a Miles Laboratory product, and calcium leucovorin (folinic acid) was purchased from Lederle Laboratories. Other chemicals were of reagent grade, when available.
Growth of cells and preparations of subcellular fractions. Strain D1O (metrns-) (3) was used. It was grown in Casamino broth medium (1) To find out whether a step uniquely sensitive to ATA exists in the initiation process, several steps in initiation were examined. In the first experiment in this series, the effect of ATA on the poly AUG-stimulated binding of f-14C-met-tRNA to ribosomes was studied (Fig. 3) reaction by inhibiting messenger binding to ribosomes or fmet-tRNA binding to the messengerribosome complex, these two reactions were dissected. In Fig. 4 , the inhibition of 3H-R17 RNA binding to purified 30S ribosomes is presented. The inhibition obtained (maximum at 350 Mm) is similar to that obtained with the poly AUGstimulated binding of f-14C-met (Fig. 3) .
In another experiment, the inhibition by ATA of the binding of fmet-tRNA to the messengerribosome complex was tested. The poly AUG was bound to ribosomes by incubation for 10 min at 25 C; then the appropriate concentrations of ATA, f-35C-met-tRNA, and GTP were added, and the incubation was continued for an additional 15 min at 25 C. The results (Fig. 5) indicate that the binding of fmet-tRNA to the messenger-ribosome complex is also sensitive to ATA and only slightly less sensitive than the binding of messenger to the 30S ribosome.
The effect of ATA on the addition of the 50S ribosome to the 30S initiation complex was also examined ( The results presented here, all of which are in agreement with previous results (4, 10, 12) , demonstrate that under proper conditions ATA is a preferential inhibitor of initiation. However, elongation can be inhibited as well (see Fig. 2 ). Inhibition of elongation is further supported by the facts that ATA inhibits polyuridylic acid-directed protein synthesis and ribosome-dependent guanosine triphosphatase (Siegelman and Apirion, J. Bacteriol., in press), as well as the function of the Ts elongation factor (I 1).
The concentrations necessary to inhibit the Gspecific, ribosome-dependent guanosine triphosphatase, R17 itself to R17 RNA is undetected in a sucrose gradient, the deficiency in 50S particles probably reflects a specific inhibition of the addition of 50S ribosome subunits to the messenger-fmet-tRNA-30S ribosome complex. synthesis directed by natural mRNA (see Fig. 1-5 ). Therefore, we assume that the preferential inhibition of initiation by ATA is the result of the sum of the inhibitions of the various steps of initiation, and therefore perhaps the total initiation process is more complex, involving more steps than the elongation process. It may be that some as yet unexamined step in initiation is sensitive to ATA to a greater extent than those already tested. However, even if such were the case, it is still an unavoidable conclusion that ATA is an inhibitor of many of the reactions of protein synthesis.
Our conclusions can be summarized as follows: (i) ATA can inhibit many steps in protein synthesis; (ii) none of the steps tested is uniquely sensitive to ATA; (iii) ATA inhibits the total initiation process of a protein chain to a greater extent than the elongation process; (iv) by use of proper concentrations of ATA, the initiation process can be inhibited completely while the elongation process is almost unaffected.
We do not know at present the mechanism by which ATA exerts its effects, i.e., whether it binds mainly to RNA or to protein, and through which chemical groups. However, there are certain indications that its effects, although of wide range, are nonetheless quite specific and probably cannot be attributed, for instance, to chelating of Mg2+ ions. This is indicated by the fact that increasing Mg2+ concentrations do not alleviate inhibition by ATA [see Fig. 3 and Siegelman and Apirion, (J. Bacteriol., in press)]. (In this lastmentioned experiment, no reversal of inhibition of polyuridylic acid-directed protein synthesis was observed when the Mg2+ concentration was raised.)
It is interesting to compare a chemical like ATA to naturally occurring antibiotics that interfere with protein synthesis. Whereas the antibiotics apparently block unique steps in the reaction and therefore can be adapted to by the organism by single-step mutations, ATA is interfering with more than one step of the reaction and an organism would not be able to adapt to it by a single-step mutation [some of our studies (unpublished observation) with E. coli strains made permeable to ATA indicate that this is indeed very likely]. Perhaps antibiotics that necessitate adaptation by more than a few mutations upset the ecological balance to such an extent that their perpetuation in nature is selected against.
